Related Experiment Videos

Hemostatic function tests associated with diabetic microangiopathy

Hormone and Metabolic Research. Supplement Series
|January 1, 1981
PubMed

Insights

Diabetics show higher blood clotting factors and lower clot breakdown, suggesting a link between thrombosis and diabetes complications. Further research is needed to confirm if this tendency causes microangiopathy.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Endocrinology

Background:

  • Diabetes mellitus is associated with an increased risk of vascular complications.
  • Hemostatic function may play a role in the development of these complications.

Purpose of the Study:

  • To investigate the association between thrombotic tendency and vascular complications in diabetic patients.
  • To compare hemostatic function in diabetics with a control group.

Main Methods:

  • Hemostatic function tests (factor VII, fibrinogen, antithrombin III, platelet adhesiveness, fibrinolytic activity) were performed on 154 diabetic patients (91 men, 63 women, aged 35-54).
  • Results were compared with 1076 individuals from the Northwick Park Heart Study.

Main Results:

  • Diabetic patients exhibited higher levels of factor VII, fibrinogen, antithrombin III, and platelet adhesiveness, alongside lower fibrinolytic activity compared to controls.
  • Diabetics with retinopathy showed elevated factor VII and antithrombin III.
  • Diabetics with proteinuria had higher factor VII, fibrinogen, and platelet adhesiveness.

Conclusions:

  • The findings suggest a significant association between increased thrombotic tendency and microangiopathy in diabetes.
  • Prospective studies are required to establish a causal relationship between these hemostatic changes and diabetic vascular complications.

Related Concept Videos